Nearly one-half of employers surveyed by WTW said they were interested in “compounded” GLP-1 medications coming onto the market at lower costs.
Health plan costs are expected to rise by 8% in 2025, driven in part by GLP-1 drugs
Tag: Total Rewards (Comp & Benefits), Health